                         SEQUENCE LISTING

<110>  LYKERA BIOMED SA
 
<120>  ANTIBODIES AGAINST THE S100P PROTEIN FOR THE TREATMENT AND 
       DIAGNOSIS OF CANCER

<130>  P6177PC00

<150>  EP 11382010
<151>  2011-01-17

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  95
<212>  PRT
<213>  Human

<400>  1

Met Thr Glu Leu Glu Thr Ala Met Gly Met Ile Ile Asp Val Phe Ser 
1               5                   10                  15      


Arg Tyr Ser Gly Ser Glu Gly Ser Thr Gln Thr Leu Thr Lys Gly Glu 
            20                  25                  30          


Leu Lys Val Leu Met Glu Lys Glu Leu Pro Gly Phe Leu Gln Ser Gly 
        35                  40                  45              


Lys Asp Lys Asp Ala Val Asp Lys Leu Leu Lys Asp Leu Asp Ala Asn 
    50                  55                  60                  


Gly Asp Ala Gln Val Asp Phe Ser Glu Phe Ile Val Phe Val Ala Ala 
65                  70                  75                  80  


Ile Thr Ser Ala Cys His Lys Tyr Phe Glu Lys Ala Gly Leu Lys 
                85                  90                  95  


<210>  2
<211>  98
<212>  PRT
<213>  Human

<400>  2

Gly Ser His Met Thr Glu Leu Glu Thr Ala Met Gly Met Ile Ile Asp 
1               5                   10                  15      


Val Phe Ser Arg Tyr Ser Gly Ser Glu Gly Ser Thr Gln Thr Leu Thr 
            20                  25                  30          


Lys Gly Glu Leu Lys Val Leu Met Glu Lys Glu Leu Pro Gly Phe Leu 
        35                  40                  45              


Gln Ser Gly Lys Asp Lys Asp Ala Val Asp Lys Leu Leu Lys Asp Leu 
    50                  55                  60                  


Asp Ala Asn Gly Asp Ala Gln Val Asp Phe Ser Glu Phe Ile Val Phe 
65                  70                  75                  80  


Val Ala Ala Ile Thr Ser Ala Cys His Lys Tyr Phe Glu Lys Ala Gly 
                85                  90                  95      


Leu Lys 
        


<210>  3
<211>  41
<212>  DNA
<213>  Artificial

<220>
<223>  S100P 5' primer

<400>  3
actcacatat gacggaacta gagacagcca tgggcatgat c                           41


<210>  4
<211>  43
<212>  DNA
<213>  Artificial

<220>
<223>  S100P 3' primer

<400>  4
actcatgagc tcatcatttg agtcctgcct tctcaaagta ctt                         43


<210>  5
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Thrombin protease cleavage site

<400>  5

Leu Val Pro Arg Gly Ser 
1               5       


